We validated the up‐regulation of UBE2V1, BNIP3L mRNAs, RP11‐128N14.5 lncRNA, TGFB2/TGFB2‐OT1 coding/lncRNA in patients with NAS ≥ 5 (vs NAS ≤ 4) and the up‐regulation of HBA2 mRNA, TGFB2/TGFB2‐OT1 coding/lncRNA in patients with Fibrosis stages = 3‐4 (vs F = 0‐2). The gene discussed is BNIP3L; the disease is fibrosis.